- Home
- Publications
- Publication Search
- Publication Details
Title
Triple Therapy in COPD: Time for Adaptive Selection Trials
Authors
Keywords
-
Journal
COPD-Journal of Chronic Obstructive Pulmonary Disease
Volume 18, Issue 6, Pages 597-601
Publisher
Informa UK Limited
Online
2021-09-28
DOI
10.1080/15412555.2021.1982886
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Perplexing mortality data from triple therapy trials in COPD
- (2021) Samy Suissa Lancet Respiratory Medicine
- Fixed Triple Therapy in COPD and Survival: Living Better, Longer, or Both?
- (2020) Jørgen Vestbo AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Reduction in All-Cause Mortality with Fluticasone Furoate/Umeclidinium/Vilanterol in COPD Patients
- (2020) David A. Lipson et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Withdrawal of Inhaled Corticosteroids in Chronic Obstructive Pulmonary Disease: A European Respiratory Society Guideline
- (2020) James D. Chalmers et al. EUROPEAN RESPIRATORY JOURNAL
- Triple Inhaled Therapy at Two Glucocorticoid Doses in Moderate-to-Very-Severe COPD
- (2020) Klaus F. Rabe et al. NEW ENGLAND JOURNAL OF MEDICINE
- Re-Igniting the TORCH: COPD Mortality and Inhaled Corticosteroids Re-Visited
- (2020) Peter Calverley AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Reduced All-Cause Mortality in the ETHOS Trial of Budesonide/Glycopyrrolate/Formoterol for COPD: A Randomized, Double-Blind, Multi-Center Parallel-Group Study
- (2020) Fernando J. Martinez et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Triple therapy in COPD: only for the right patient
- (2019) Samy Suissa et al. EUROPEAN RESPIRATORY JOURNAL
- Long-term Triple Therapy De-escalation to Indacaterol/Glycopyrronium in COPD Patients (SUNSET): a Randomized, Double-Blind, Triple-Dummy Clinical Trial
- (2018) Kenneth R Chapman et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Extrafine inhaled triple therapy versus dual bronchodilator therapy in chronic obstructive pulmonary disease (TRIBUTE): a double-blind, parallel group, randomised controlled trial
- (2018) Alberto Papi et al. LANCET
- Making Sense of Triple Inhaled Therapy for COPD
- (2018) Samy Suissa et al. NEW ENGLAND JOURNAL OF MEDICINE
- Once-Daily Single-Inhaler Triple versus Dual Therapy in Patients with COPD
- (2018) David A. Lipson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Key design considerations for adaptive clinical trials: a primer for clinicians
- (2018) Kristian Thorlund et al. BMJ-British Medical Journal
- Key design considerations for adaptive clinical trials: a primer for clinicians
- (2018) Kristian Thorlund et al. BMJ-British Medical Journal
- Triple therapy with budesonide/glycopyrrolate/formoterol fumarate with co-suspension delivery technology versus dual therapies in chronic obstructive pulmonary disease (KRONOS): a double-blind, parallel-group, multicentre, phase 3 randomised controlled trial
- (2018) Gary T Ferguson et al. Lancet Respiratory Medicine
- Triple therapy trials in COPD: a precision medicine opportunity
- (2018) Samy Suissa et al. EUROPEAN RESPIRATORY JOURNAL
- Global Initiative for Chronic Obstructive Lung Disease (GOLD) 20th Anniversary: a brief history of time
- (2017) Roberto Rodriguez-Roisin et al. EUROPEAN RESPIRATORY JOURNAL
- Bias from depletion of susceptibles: the example of hormone replacement therapy and the risk of venous thromboembolism
- (2017) Christel Renoux et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- Fluticasone furoate and vilanterol and survival in chronic obstructive pulmonary disease with heightened cardiovascular risk (SUMMIT): a double-blind randomised controlled trial
- (2016) Jørgen Vestbo et al. LANCET
- Single inhaler triple therapy versus inhaled corticosteroid plus long-acting β2-agonist therapy for chronic obstructive pulmonary disease (TRILOGY): a double-blind, parallel group, randomised controlled trial
- (2016) Dave Singh et al. LANCET
- Assessing the Gold Standard — Lessons from the History of RCTs
- (2016) Laura E. Bothwell et al. NEW ENGLAND JOURNAL OF MEDICINE
- Appropriate use of inhaled corticosteroids in COPD: the candidates for safe withdrawal
- (2016) Barbara P Yawn et al. npj Primary Care Respiratory Medicine
- INSTEAD: a randomised switch trial of indacaterolversussalmeterol/fluticasone in moderate COPD
- (2014) Andrea Rossi et al. EUROPEAN RESPIRATORY JOURNAL
- Withdrawal of Inhaled Glucocorticoids and Exacerbations of COPD
- (2014) Helgo Magnussen et al. NEW ENGLAND JOURNAL OF MEDICINE
- Tiotropium Respimat Inhaler and the Risk of Death in COPD
- (2013) Robert A. Wise et al. NEW ENGLAND JOURNAL OF MEDICINE
- The Hazards of Hazard Ratios
- (2009) Miguel A. Hernán EPIDEMIOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now